Loading...
Pharmacotherapy of mild cognitive impairment
Amnestic mild cognitive impairment (MCI) can be considered as a state with a high risk of developing Alzheimer's disease within 5 years, or as a prodromal stage of this condition. Randomized clinical trials comparing the acetylcholinesterase inhibitor donepezil with placebo have shown some symp...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Les Laboratoires Servier
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181817/ https://ncbi.nlm.nih.gov/pubmed/22034396 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|